drugset / Trial / NCT02818348
Clinical Trial to Evaluate Drug-drug Interactions Between Darunavir/Cobicistat and Etravirine in Hiv- Infected Patients
Non-randomizedParallel-groupOpen-labelBasic science
Summary
This study aims to provide information about the safety and pharmacokinetic drug-drug interactions between darunavir/cobicistat (800/150mg QD) and etravirine (400mg QD) in HIV-infected patients, as well as evaluate the efficacy of concomitant administration of darunavir/cobicistat and etravirine.
Timeline
- Start
- 2016-06
- Primary completion
- 2016-10
- Completion
- 2016-11-23
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cobicistat | Small molecule | 150 mg | — |
| Subject | Darunavir | Small molecule | 800 mg | — |
| Subject | Etravirine | Small molecule | 400 mg | — |